Arbro Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-12-2024
- Paid Up Capital ₹ 1.00 M
as on 02-12-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.44 Cr
as on 02-12-2024
About Arbro Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹12.44 Cr.
Saurabh Arora and Vijay Arora serve as directors at the Company.
- CIN/LLPIN
U24230DL2022PTC395692
- Company No.
395692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arbro Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Arora  | Director | 29-Mar-2022 | Current |
| Vijay Arora | Director | 29-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Arbro Formulations.
Arbro Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Arbro Formulations?
In 2023, Arbro Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
India Section Of Association Of Official Analytical Chemists InternationalActive 11 years 10 monthsSaurabh Arora is a mutual person
Alcatec Research Laboratories India Private LimitedActive 28 years 8 monthsSaurabh Arora and Vijay Arora are mutual person
Auriga Research Private LimitedActive 29 years 11 monthsSaurabh Arora and Vijay Arora are mutual person
Arbro Pharmaceuticals Private LimitedActive 39 years 5 monthsSaurabh Arora and Vijay Arora are mutual person
Ningen Skin Sciences Private LimitedActive 1 year 11 monthsSaurabh Arora and Vijay Arora are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Aug 2024 | ₹3.00 Cr | Open |
Others Creation Date: 04 Jul 2024 | ₹2.00 Cr | Open |
Tata Capital Financial Services Limited Creation Date: 06 Jul 2023 | ₹4.88 Cr | Open |
How Many Employees Work at Arbro Formulations?
Arbro Formulations has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arbro Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arbro Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
